Solius Labs, Inc. — SEC Form D Filing

Solius Labs, Inc. filed an SEC Form D on May 14, 2026, reporting $3.50M raised in Health Technology.

Form D filing details

Filing
SEC Form D
Filing date
May 14, 2026
Amount reported
$3.50M
Round stage
Pre-Seed
Industry
Health Technology
Website
https://www.solius.com/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

People may experience insufficient exposure to beneficial sunlight, leading to potential health issues without a way to safely manage UV exposure.

Solution

Solius Labs, Inc. is developing a personalized sunlight device that analyzes your skin and delivers an optimal dose of UVB light therapy with minimal UV risk.

Why now

As awareness of the health benefits of sunlight increases, there is a growing need for safe and personalized UV exposure solutions.

Verdict

Investors rallied behind Solius Labs because the urgency around personalized health solutions offered a fresh narrative in a crowded wellness market, not because the device significantly differentiated itself from existing options. They implicitly bet on rising health trends and the increasing awareness of UV exposure's benefits to attract health-conscious consumers. However, the limited upside lies in an unproven technology and the possibility of rapid commoditization as similar products emerge.

Source: SEC EDGAR Form D filing